Neuroscience, Pain, and Psychiatry Experience
Medpace has conducted Phase I-IV neuroscience trials around the world.
Our physicians and staff are experienced in the following areas:
|Alzheimer’s disease||Acute pain||Addictive Disorders|
|Epilepsy||Chronic non-cancer pain||Anxiety Disorders|
|Fragile X syndrome||Neuropathic pain||Attention-Deficit/Hyperactivity Disorder|
|Huntington disease||Opioid-induced constipation||Bipolar Disorder|
|Ischemic stroke||Cognition Disorders|
|Multiple sclerosis||Developmental Disorders|
|Muscular dystrophy||Eating Disorders|
|Parkinson’s Disease||Neuropsychiatric Disorders|
|Subarachnoid hemorrhage||Sleep Disorders|
|TTR amyloidosis||Learn More|
Specialized Imaging for Neuroscience Clinical Research
High-quality image acquisition and interpretation is crucial for the success of trials relying on neuroimaging for patient selection or as a primary endpoint. Medpace provides centralized neuroimaging expertise, led by radiologists and neurologists with decades of clinical and trial experience.
Medpace Imaging Core Lab provides an end-to-end suite of imaging services to enhance and expedite biopharmaceutical and imaging contrast agent development, including consultation on imaging biomarker strategies, image acquisition protocols, image collection/archiving services, and image analysis across imaging modalities and therapeutic areas. Capabilities include:
- Standard diagnostic imaging
- Magnetic resonance imaging (MRI)
- Computed tomography (CT)
- Bone densitometry or dual-energy x-ray absorptiometry (DXA)
Lending Our Support
Medpace is an active member of the Alliance for Regenerative Medicine, a Washington, DC-based non-profit organization whose mission is to educate key policy makers about the potential of regenerative medicine and to advocate for favorable public policies—funding, regulatory, reimbursement and others—to facilitate advances in the field.